FDBusiness.com

Biotech Company Nuritas Discovers New MRSA Killing Peptide

 Breaking News
  • Dairy Crest to Invest £85 Million to Expand Cheese Business Dairy Crest, the leading British-owned dairy company, is investing £85 million in growing the capacity of its cheese business, £75 million of which will be invested at its Davidstow creamery in Cornwall. The investment will allow further growth of the company’s market-leading cheese brands Cathedral City and Davidstow, enhance whey production capacity and support farmers [...]...
  • Record Annual Sales and Capital Investment at Cranswick Driven by robust growth across all product categories – Fresh Pork, Convenience, Gourmet Products and Poultry – as well as a 30.2% increases in exports, Cranswick, the UK food group, has increased total revenue by 18% to a record £1.464.5 billion for the year ended 31 March 2018. Like-for-like revenue increased 13% over the prior [...]...
  • Challenging First Half For Greencore Group Greencore Group, a leading manufacturer of convenience food in the UK and US, has reported revenue of £1.239 billion for the 26 weeks ended 30 March 2018, up by 22.6% versus first half of 2017. Adjusted operating profit of £59.7 million was 8.0% higher than the corresponding period in 2017, primarily driven by the acquisition [...]...
  • Lurpak Combines Taste and Convenience For Launch of New Softest Arla Foods UK is to expand its spreadable product portfolio with the launch of Lurpak Softest, a new soft blend butter that is spreadable straight from the fridge. The UK’s number one butter brand has combined the great taste that Lurpak is renowned for with the softest, most spreadable butter ever*. With spreadability the most important [...]...
  • Scientific Study Shows Improved Fat Oxidation and Better Performance in Athletes When Using BENEO’s Palatinose™ A scientific study by Professor Daniel König[i] and his team at the Department of Sports and Sport Sciences of the University of Freiburg, Germany, has shown that with a pre-load of Palatinose™ endurance athletes “maintained a more stable blood glucose profile and higher fat oxidation, which resulted in improved cycling performance compared with maltodextrin.” The study used a [...]...

Biotech Company Nuritas Discovers New MRSA Killing Peptide

December 06
15:42 2014

Nuritas PhotoIrish bioinformatics company, Nuritas, today announced that it has discovered an MRSA killing peptide. The peptide, which is derived from a food by-product, is anticipated to provide a natural, healthy innovation in the fight against antibiotic resistant infections in both humans and animals.

Nuritas’ ground-breaking biotechnology is capable of quickly and cost-effectively harvesting ingredients which then may be developed and supplied to humans and animal producers for many different applications from topical applications to effective cleaning biocides.

Dr. Nora Khaldi, CEO of Nuritas, states “Our aim is to make ingredients that are more accessible, natural and meeting serious societal health needs.”

Unlike existing MRSA killing products, Nuritas has found a way to rapidly and effectively extract and activate safe and healthy antimicrobial molecules in food that are often overlooked. This is a world first in that most molecules are usually derived from non-sustainable sources that have unknown side effects on human health and cost millions and years to develop.

Dr. Marta Martins, Biotechnology Research Fellow at University College Dublin said that “The increase of antibiotic resistance in bacteria of clinical relevance is a major issue for Public Health and there is the immediate need for alternative solutions”. Nuritas’ announcement today of the discovery of an effective and natural peptide to combat MRSA comes at a crucial point in the MRSA battle it seems.

Staphylococcus aureus is a bacterium commonly found in the nose and/or skin of healthy persons and animals. Strains of this bacterium that are resistant to beta-lactam antibiotics are called Methicillin-Resistant Staphylococcus aureus (MRSA). If this bacterium penetrates the skin and enters the blood stream it can cause life-threatening infections due to its resistance to many of the currently used antibiotics.

The inappropriate use of antibiotics in human treatments and animal production is contributing to antibiotic resistance, allowing bacterium such as Staphylococcus aureus to continue to evolve. Developing treatments to keep up with the evolution of the bacterium are costly and time-consuming. Severe side effects are also associated with some of the second or last-line antibiotic treatments. Nuritas’ ingredients are cost-effectively and quickly mined from food sources eliminating the possible severe side effects associated with current therapies and uses.

Overall, Nuritas’ discovery has the potential to provide innovative treatment of the costly and dangerous MRSA causing-infections by providing affordable, healthy, sustainable anti-microbials to ensure the healthy, long life of humans and animals.

 

About Nuritas

downloadNuritas is a biotechnology company that radically changes the way we discover natural peptides that target key receptors to actively promote and manage health. The company uses artificial intelligence to data mine food, allowing the discovery of life-changing ingredients that can be added to personal care products, supplements, food or biocides. Nuritas is committed to applying its scientific expertise to translate nature into healthy, sustainable and cost-effective living for all.

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • May 21, 2018London Int'l Wine Fair
  • May 22, 2018European Coffee Expo
  • June 1, 2018Gluten Free Expo Slovakia
  • June 3, 2018Vinoble
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements